Vendor Analysis
published on Jan 20, 2022
Report Overview:
This NelsonHall vendor assessment analyzes Genpact's offerings and capabilities in Pharmaceuticals / Life Sciences Operational Transformation
Who is this Report for:
NelsonHall’s pharmaceuticals / life sciences operational transformation profile on Genpact is a comprehensive assessment of Genpact’s offerings and capabilities, designed for:
- Sourcing managers monitoring the capabilities of existing suppliers of pharmaceuticals / life sciences operational transformation services and identifying vendor suitability for operational transformation services RFPs
- Vendor marketing, sales, and business managers looking to benchmark themselves against their peers
- Financial analysts and investors specializing in the pharmaceuticals / life sciences services sector.
Scope of this Report:
The report provides a comprehensive and objective analysis of Genpact’s pharmaceuticals / life sciences operational transformation offerings and capabilities, and market and financial strengths, including:
- Identification of the company’s strategy, emphasis, and new developments
- Analysis of the company’s strengths, weaknesses, and outlook
- Revenue estimates
- Analysis of the profile of the company’s customer base, including the company’s targeting strategy and examples of current contracts
- Analysis of the company’s offerings and key service components
- Analysis of the company’s delivery organization, including the location of delivery locations.
Key Findings & Highlights:
Genpact has been working with pharmaceutical and life sciences clients for over 15 years, and it is its longest-standing industry vertical. It currently offers a wide range of services, including:
- Consulting (digital experience and innovation, IA, AI, advanced analytics, technology consulting)
- Proprietary technology powered by Cora Digital platform
- Analytics for life sciences (sales analytics, marketing analytics, regulatory analytics, R&D analytics)
- Managed services.